Christopher English

Christopher English is an experienced professional in the biotechnology field, currently serving as a Business Intelligence Developer at Dendreon since September 2016. Previously, Christopher held roles as a Manufacturing Operations Coordinator and Manufacturing Operations Associate (Lead Investigator) focused on quality and compliance for Provenge, the first FDA-approved autologous immunotherapy for cancer treatment. Prior experience includes founding English Enterprises Biotechnical, where Christopher worked as a biochemist and consultant. Christopher's early career included positions as an assistant at Colorado State University, managing lab equipment and waste, and as a lab technician at The Nyborg Lab, contributing to various research activities. Christopher holds a Bachelor of Science in Biochemistry from Colorado State University.